Workshop C Comparatively Assess Novel & Disease- Specific Targets vs. Upstream Broad-Spectrum Targets to Unveil Untapped Opportunities for Enhanced IPF Therapeutics
Time: 11:30 am
day: Pre-Conference Workshop C
Details:
• Exploring specific and isolated drivers of IPF including ECM,
fibroblasts, macrophages, epithelial and endothelial cells as
opposed to generic processes
• Minimizing off target effects with novel disease-specific
pathways and targets to halt fibrosis with greater precision
• Targeting upstream non-specific processes affecting multiple
downstream pro-fibrotic pathways
• Finding the balance between strength and specificity and
optimal patient populations for different approaches
• What have the community tried, what avenues still need to be
explored and where do remaining opportunities lie?
